An Interview With Thomas Holm Pedersen, PhD, Cofounder and CEO of Denmark's NMD Pharma

14/03/2024 14 min Temporada 1 Episodio 114
An Interview With Thomas Holm Pedersen, PhD, Cofounder and CEO of Denmark's NMD Pharma

Listen "An Interview With Thomas Holm Pedersen, PhD, Cofounder and CEO of Denmark's NMD Pharma"

Episode Synopsis

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Thomas Holm Pedersen, PhD, cofounder and chief executive of NMD Pharma, a Danish company that's pursuing the use of chloride channel 1 (ClC-1) as a novel target for restoring muscle function in both myasthenia gravis and spinal muscular atrophy.

More episodes of the podcast Rare Care Podcast